2C-T-29
2C-T-29, also known as 2C-T-PARGY or 2C-T-PROPARGYL or as 4-propargylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
2C-T-29, also known as 2C-T-PARGY or 2C-T-PROPARGYL or as 4-propargylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a potent agonist at the serotonin receptor 5-HT 2A in vitro, with a binding affinity (K i ) of 1.3 nM and an EC 50 of 0.67 nM, acting as a full agonist.
While the closely related propylthio compound 2C-T-7 and the allylthio derivative 2C-T-16 are both known to be potent psychedelic drugs in humans, the propargylthio analogue 2C-T-29 is not known to have been tested in humans or other animals. It is a controlled substance in Canada under phenethylamine blanket-ban language.
2C-T-29, also known as 2C-T-PARGY or 2C-T-PROPARGYL or as 4-propargylthio-2,5-dimethoxyphenethylamine, is a designer drug from the substituted phenethylamine family, which was first synthesised by Josh Hartsel and colleagues in 2024. It is a potent agonist at the serotonin receptor 5-HT 2A in vitro, with a binding affinity (K i ) of 1.3 nM and an EC 50 of 0.67 nM, acting as a full agonist.
While the closely related propylthio compound 2C-T-7 and the allylthio derivative 2C-T-16 are both known to be potent psychedelic drugs in humans, the propargylthio analogue 2C-T-29 is not known to have been tested in humans or other animals. It is a controlled substance in Canada under phenethylamine blanket-ban language.
External links
2C-T-29 - Isomer Design
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371212413 under CC BY-SA 4.0; modifications have been made.